4-AcO-DPT
Names | |
---|---|
Preferred IUPAC name
3-[2-(Diethylamino)ethyl]-1H-indol-4-yl acetate | |
Other names
Depracetin | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C18H26N2O2 |
Molar mass | 302.418 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
4-Acetyloxy-N,N-dipropyltryptamine (or 4-AcO-DPT) is a tryptamine derivative. 4-AcO-DPT has been sold as a designer drug.[1] It is an ester of 4-HO-DPT, a psychedelic tryptamine first synthesized by Alexander Shulgin. Anecdotal reports indicate that 4-AcO-DPT exerts psychoactive effects in humans, however, the pharmacology of 4-AcO-DPT has not been examined.[2][3]
See also
References
- ↑ Schifano, Fabrizio; Orsolini, Laura; Papanti, Duccio; Corkery, John (2017). Neuropharmacology of new psychoactive substances (NPS) : the science behind the headlines. Current Topics in Behavioral Neurosciences. Vol. 32. Cham, Switzerland: Springer. pp. 351–380. doi:10.1007/978-3-319-52444-3. ISBN 978-3-319-52444-3. S2CID 23812562. Retrieved 14 January 2021.
- ↑ Nervewing. "Greater Mind Lesser Body". Erowid Experience Vaults. Erowid. Retrieved 14 January 2021.
- ↑ "Tihkal 4-HO-DIPT entry".
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.